ETADX
Price
$18.89
Change
-$0.25 (-1.31%)
Updated
Jun 13 closing price
Net Assets
1.15B
VEXMX
Price
$140.69
Change
-$2.43 (-1.70%)
Updated
Jun 13 closing price
Net Assets
107.69B
Interact to see
Advertisement

ETADX vs VEXMX

Header iconETADX vs VEXMX Comparison
Open Charts ETADX vs VEXMXBanner chart's image
Eventide Dividend Growth A
Price$18.89
Change-$0.25 (-1.31%)
VolumeN/A
Net Assets1.15B
Vanguard Extended Market Index Investor
Price$140.69
Change-$2.43 (-1.70%)
VolumeN/A
Net Assets107.69B
ETADX vs VEXMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ETADX vs. VEXMX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETADX is a Buy and VEXMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 108B vs. ETADX (1.15B). VEXMX pays higher dividends than ETADX: VEXMX (1.08) vs ETADX (0.42). ETADX was incepted earlier than VEXMX: ETADX (8 years) vs VEXMX (38 years). ETADX (1.21) is less costly to investors than VEXMX (0.19). ETADX is a more actively managed with annual turnover of: 38.00 vs. VEXMX (11.00). ETADX has a lower initial minimum investment than VEXMX: ETADX (1000) vs VEXMX (3000). VEXMX annual gain was more profitable for investors over the last year : 10.34 vs. ETADX (6.40). ETADX return over 5 years is better than : 84.17 vs. VEXMX (63.64).
ETADXVEXMXETADX / VEXMX
Total Expense Ratio1.200.19632%
Annual Report Gross Expense Ratio1.210.19637%
Fund Existence8 years38 years-
Gain YTD1.222-2.361-52%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.15B108B1%
Annual Yield % from dividends0.421.0839%
Returns for 1 year6.4010.3462%
Returns for 3 years44.9442.87105%
Returns for 5 years84.1763.64132%
Returns for 10 yearsN/A105.37-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KNSA28.300.57
+2.06%
Kiniksa Pharmaceuticals International plc
MTSI128.97-3.32
-2.51%
MACOM Technology Solutions Holdings
ZVRA9.13-0.24
-2.56%
Zevra Therapeutics
WHWK1.96-0.08
-3.92%
Whitehawk Therapeutics Inc
NUWE0.28-0.04
-11.20%
Nuwellis Inc